Christopher A Giuliano
Overview
Explore the profile of Christopher A Giuliano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kale-Pradhan P, Pacitto R, Giuliano C, Johnson L
Curr Drug Saf
. 2023 Aug;
19(3):350-355.
PMID: 37592771
Introduction: Anti-inflammatory agents like dexamethasone (DEX) are a mainstay of treatment for COVID-19. Despite randomized trials demonstrating that a 6 mg daily dose of DEX improved patient outcomes in hospitalized...
2.
Lipari M, Wilhelm S, Giuliano C, Martirosov A, Salinitri F
Curr Pharm Teach Learn
. 2022 Mar;
14(3):352-358.
PMID: 35307096
Background And Purpose: There has been an increased use of active learning pedagogies in pharmacy curricula. Structured, complex pedagogies such as problem-based learning (PBL) may require rigorous training for students...
3.
Berti A, Kale-Pradhan P, Giuliano C, Aprilliano B, Miller C, Alyashae B, et al.
Curr Drug Saf
. 2022 Mar;
17(4):366-369.
PMID: 35301954
Background: Zinc supplementation is frequently prescribed during the treatment of COVID-19. However, the evidence supporting the efficacy of this intervention is mixed. Objective: Establish the clinical utility of zinc supplementation...
4.
McConachie S, Berri D, Konja J, Giuliano C
J Med Libr Assoc
. 2022 Feb;
110(1):81-86.
PMID: 35210966
Objective: To evaluate the differences in presentation (formatting) of adverse drug reaction (ADR) information within drug monographs in commonly used drug information (DI) mobile device applications. Methods: A cross-sectional analysis...
5.
George J, Giuliano C, Hartner C
J Pharm Pract
. 2021 May;
:8971900211017867.
PMID: 34002663
Background: Prior research has demonstrated increased mortality with increasing glycemic variability (GV) in hospitalized patients with diabetes. Objective: We aimed to compare glycemic variability (GV) of insulin glargine to detemir...
6.
DeBiase C, Giuliano C, Doshi M, Ganoff M, Paxton R
Pharmacotherapy
. 2021 Feb;
41(5):424-429.
PMID: 33641194
Introduction: Intensive care unit (ICU) patients with renal insufficiency are more likely to develop venous thromboembolism and are at an increased risk for bleeding. There is conflicting data on whether...
7.
McConachie S, Volgyi D, Moore H, Giuliano C
J Med Libr Assoc
. 2020 Oct;
108(4):598-604.
PMID: 33013217
Objective: The research evaluated the differences in formatting of adverse drug reaction (ADR) information in drug monographs in commonly used drug information (DI) databases. Methods: A cross-sectional analysis of formatting...
8.
McConachie S, Giuliano C, Mohammad I, Kale-Pradhan P
J Med Libr Assoc
. 2020 Jan;
108(1):76-83.
PMID: 31897054
Objective: Formatting of adverse drug reaction (ADR) information differs among drug information (DI) resources and may impact clinical decision-making. The objective of this study was to determine whether ADR formatting...
9.
Neu R, Leonard M, Dehoorne M, Scalia S, Kale-Pradhan P, Giuliano C
Ann Pharmacother
. 2019 Oct;
54(3):239-246.
PMID: 31602994
Heart failure (HF) transition of care (TOC) programs may improve continuity of care and coordination and decrease hospital readmissions. This study evaluated the impact of pharmacy-led HF TOC on HF...
10.
Crisher M, Giuliano C, Hartner C
Clin Diabetes
. 2019 May;
37(2):167-171.
PMID: 31057223
Several studies have compared the safety and efficacy of insulin detemir and insulin glargine; however, most have been conducted in the ambulatory care setting. This retrospective cohort study compared hypoglycemia...